NCT02273219 2023-08-15Trial of AEB071 in Combination With BYL719 in Patients With MelanomaColumbia UniversityPhase 1 Completed30 enrolled
NCT01402440 2020-12-19Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell LymphomaNovartisPhase 1 Terminated15 enrolled
NCT01430416 2020-12-19Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma PatientsNovartisPhase 1 Completed153 enrolled